Hepatobiliary Cancers

Hepatobiliary cancers are growths of abnormal cells that form in the liver, pancreas, gallbladder and bile ducts. These cancers are collectively termed "hepatobiliary" due to their involvement in the hepatobiliary system, which is responsible for the production, storage and transportation of bile, a fluid crucial for digestion.

Since each type of hepatobiliary cancer is unique, with different signs, symptoms, risk factors and prevention strategies, the healthcare professionals at the Summa Health Cancer Institute combine the latest technology with a comprehensive course of cancer treatment options.

Symptoms of hepatobiliary cancers can vary but often include:

• Jaundice: Yellowing of the skin and eyes, often due to bile duct obstruction.
• Abdominal Pain: Particularly in the upper right quadrant.
• Weight Loss: Unintended and significant weight loss.
• Fatigue: Persistent and unexplained tiredness.
• Loss of Appetite: Decreased desire to eat.
• Nausea and Vomiting: Digestive disturbances.

Preventive Screenings

Screenings for hepatobiliary cancers aim to detect the disease at an early stage when treatment is more likely to be effective. Screening for these cancers generally involves a combination of imaging techniques (ultrasound, CT, MRI), blood tests (tumor markers and liver function tests) and endoscopic procedures when necessary. The choice of screening tools and the frequency of screening depend on the individual's risk factors and the specific type of hepatobiliary cancer being monitored.

Treatment

Treatment for hepatobiliary cancers depends on several factors, such as the tumor’s grade and stage and the patient’s preference. Common options include surgery, radiation therapy, chemotherapy, targeted therapy and liver transplantation in certain cases of liver cancer. 

At Summa Health, we offer the latest treatments for hepatobiliary cancers, with a range of services tailored for you and your unique needs.